[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 2,417
Citations 0
Editorial
April 2017

A Year in Review

Author Affiliations
  • 1Department of Neurology, University of California, San Francisco
  • 2Editor, JAMA Neurology
JAMA Neurol. 2017;74(4):383. doi:10.1001/jamaneurol.2016.6004

We here at JAMA Neurology want to thank our authors, reviewers, and readers for their contributions in 2016. A journal’s success is firmly rooted in the quality of its contributors, and we cannot thank you all enough for your efforts to make JAMA Neurology grow and flourish. Our increasing number of manuscripts received and reviewed has led to a high-quality publication that is widely read and frequently accessed online (Table).

Table.  
JAMA Neurology Statistics for 2016
JAMA Neurology Statistics for 2016

The journal’s overall acceptance rate was 17% and 11% for research articles. Editorial decisions were made quickly by Roger Rosenberg and his team, with initial decisions on papers that were not sent out for external peer review being made in a median of 1 day and submission to acceptance, including the time for review and revision, occurring in a median of 39 days. Accepted articles were published online first quickly every week, in a median of 79 days. The journal’s Impact Factor increased to 8.2.

JAMA Neurology’s reach continued to expand as well, with more than 4.1 million article views and downloads in 2016, 36 888 recipients of the journal’s electronic Table of Contents each week, and increases in the journal’s followers on social media. In addition, JAMA Neurology articles had 6494 mentions in the news media in 2016.

We invite all readers to sign up for our weekly email table of contents at our newly designed website http://www.jamaneurology.com, follow us on Twitter @JAMANeuro, and join us on Facebook to stay up-to-date on the most important advances in neurology.

Back to top
Article Information

Corresponding Author: S. Andrew Josephson, MD, Department of Neurology, University of California, San Francisco, 505 Parnassus Ave, PO Box 0114, San Francisco, CA 94143 (andrew.josephson@ucsf.edu).

Published Online: February 6, 2017. doi:10.1001/jamaneurol.2016.6004

Conflict of Interest Disclosures: None reported.

References
1.
Gomm  W, von Holt  K, Thomé  F,  et al.  Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis.  JAMA Neurol. 2016;73(4):410-416.PubMedGoogle ScholarCrossref
2.
Savica  R, Grossardt  BR, Bower  JH, Ahlskog  JE, Rocca  WA.  Time trends in the incidence of Parkinson disease.  JAMA Neurol. 2016;73(8):981-989.PubMedGoogle ScholarCrossref
3.
Su  FC, Goutman  SA, Chernyak  S,  et al.  Association of environmental toxins with amyotrophic lateral sclerosis.  JAMA Neurol. 2016;73(7):803-811.PubMedGoogle ScholarCrossref
×